Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $207.00 at Bank of America
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its target price raised by equities researchers at Bank of America from $190.00 to $207.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the medical instruments supplier’s stock. Bank of America‘s target price would suggest a potential upside [...]